A number of ligands, including CXCL1, CXCL2, CXCL5, and CXCL8, converge on CXCR2, thereby coordinating neutrophil recruitment, angiogenesis, epithelial–mesenchymal transition, and tumor proliferation. The gene discussed is CXCL1; the disease is neoplasm.